NCT05582668Completed
Sarcopenia After Bariatric Surgery in Older Patients: a Cohort Study
Source: ClinicalTrials.gov · Last updated 25 Feb 2025
Brief summary (registry, in English)
The retrospective cohort study will compare the prevalence of sarcopenia and associated factors between older patients who have undergone bariatric surgery and older patients with obesity without previous bariatric surgery.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 12 Oct 2022
- Start date
- 3 Oct 2022
- Primary completion date
- 14 Jul 2024
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Diseases
- Obesity
- NCT number
- NCT05582668
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 3 Oct 2022 to the primary completion date, 14 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Current diagnosis of cancer
- Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Stage 3, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4.
- Neuromuscular degenerative conditions
Other
- Immobility
Who the study is looking for
- Signed informed consent
- Age 65 years or older
- Cohort 1 (exposed): Previous bariatric surgery for obesity at least 1 one year ago
- Cohort 2 (unexposed): No previous weight loss surgery
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Obesity Clinic University Hospitals Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.